Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

Presentation TCT 2025

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

Presenter: Richard Tan

October 26, 2025

Presentation TCT 2025

The Inflammatory Core of Coronary Artery Disease

Presenter: Dominick J. Angiolillo

October 26, 2025

Presentation TCT 2024

What I Learned from my Most Memorable Experiences with Atypical Coronary Disease (Inflammatory, Neoplastic etc.)

Presenter: Alfredo Rodriguez

October 28, 2024

Presentation SCAD 2022

Relationship Between Systemic Inflammatory Diseases & SCAD

Presenter: Marysia Tweet

February 19, 2022

Presentation SCAD 2021

Can Systemic Inflammatory Diseases Cause SCAD or a Bystander?

Presenter: Marysia Tweet

January 30, 2021

Presentation TCT 2020

TCT 363: To Assess the Newer Inflammatory Markers in Takayasu’s Arteritis and to Determine the Correlation of Markers With Disease Activity

Presenter: Antony Pathadan

October 14, 2020

Presentation TCT 2017

The Inflammatory Hypothesis After CANTOS: CIRT

Presenter: Bernard J. Gersh, Robert A. Harrington, Wolfgang Koenig

October 30, 2017

Presentation ESC 2017

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Presenter: Paul M. Ridker

August 27, 2017

Presentation TCT 2012

Vulnerable Plaque Is a Systemic Inflammatory and Vascular Disease

Presenter: Valentin Fuster

October 23, 2012

Advertisement

TCT 774: Anti-inflammatory Nanoparticles for Enhanced Treatment of Peripheral Arterial Disease

The Inflammatory Core of Coronary Artery Disease

What I Learned from my Most Memorable Experiences with Atypical Coronary Disease (Inflammatory, Neoplastic etc.)

Relationship Between Systemic Inflammatory Diseases & SCAD

Can Systemic Inflammatory Diseases Cause SCAD or a Bystander?

TCT 363: To Assess the Newer Inflammatory Markers in Takayasu’s Arteritis and to Determine the Correlation of Markers With Disease Activity

The Inflammatory Hypothesis After CANTOS: CIRT

Anti-Inflammatory Therapy with Canakinumab for Atherosclerotic Disease

Vulnerable Plaque Is a Systemic Inflammatory and Vascular Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content